ENDOINFORM
Live / Allowed — Notice of allowance issued (as of 30 Dec 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 21 Nov 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98866158
- Mark type
- Design + words
- Filed
- 21 Nov 2024
- Published for opposition
- 06 May 2025
- Attorney of record
- Melissa Hunter-Ensor
Goods and services
- Class 005 — Pharmaceuticals: diagnostic kits, including co-diagnostic kits, companion diagnostic kits, consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; Reagents, diagnostic preparations for medical purposes, all of the foregoing, excluding pharmaceuticals
Owner
- Aspira Women's Health Inc., Austin, TX, US
- Aspira Women's Health Inc., Austin, TX, US
Prosecution history
- 30 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 13 Nov 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 05 Oct 2025 — POST PUBLICATION AMENDMENT - ENTERED
- 01 Oct 2025 — ASSIGNED TO PETITION STAFF
- 25 Aug 2025 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 06 May 2025 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 06 May 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 May 2025 — PUBLISHED FOR OPPOSITION
- 30 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Apr 2025 — EXAMINER'S AMENDMENT ENTERED
- 04 Apr 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 04 Apr 2025 — EXAMINERS AMENDMENT E-MAILED
- 04 Apr 2025 — EXAMINERS AMENDMENT -WRITTEN
- 31 Mar 2025 — ASSIGNED TO EXAMINER